Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention

Hepatology. 2017 Mar;65(3):1075-1076. doi: 10.1002/hep.28999. Epub 2017 Feb 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin*
  • Bile Duct Neoplasms
  • Bile Ducts, Intrahepatic
  • Cardiovascular Diseases
  • Cholangiocarcinoma*
  • Humans
  • Platelet Aggregation Inhibitors
  • Risk Factors

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin